Bellicum Pharmaceuticals, Inc. (BLCM): Price and Financial Metrics
BLCM Price/Volume Stats
Current price | $0.07 | 52-week high | $1.31 |
Prev. close | $0.08 | 52-week low | $0.06 |
Day low | $0.07 | Volume | 6,000 |
Day high | $0.09 | Avg. volume | 22,874 |
50-day MA | $0.11 | Dividend yield | N/A |
200-day MA | $0.29 | Market Cap | 726.83K |
BLCM Stock Price Chart Interactive Chart >
Bellicum Pharmaceuticals, Inc. (BLCM) Company Bio
Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The company was founded in 2004 and is based in Houston, Texas.
Latest BLCM News From Around the Web
Below are the latest news stories about BELLICUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate BLCM as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday! |
Why Is Immuron (IMRN) Stock Up 67% Today?Immuron (IMRN) stock is gaining on Monday thanks to an update from the Food and Drug Administration (FDA) on a clinical hold. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayPre-market stock movers are a hot topic on Monday as we dive into the biggest winners and losers traders need to know about this morning! |
Why Is Aptorum (APM) Stock Down 16% Today?Aptorum (APM) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq. |
Why Is Bellicum Pharmaceuticals (BLCM) Stock Up 75% Today?Bellicum Pharmaceuticals (BLCM) stock is rising higher on Monday morning following news of an investment in the company. |
BLCM Price Returns
1-mo | -12.61% |
3-mo | -53.33% |
6-mo | -78.79% |
1-year | -76.27% |
3-year | -97.93% |
5-year | -99.79% |
YTD | -53.33% |
2023 | -79.17% |
2022 | -51.68% |
2021 | -57.79% |
2020 | -72.64% |
2019 | -55.82% |
Continue Researching BLCM
Want to see what other sources are saying about Bellicum Pharmaceuticals Inc's financials and stock price? Try the links below:Bellicum Pharmaceuticals Inc (BLCM) Stock Price | Nasdaq
Bellicum Pharmaceuticals Inc (BLCM) Stock Quote, History and News - Yahoo Finance
Bellicum Pharmaceuticals Inc (BLCM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...